Correlation Between Natera and Fate Therapeutics
Can any of the company-specific risk be diversified away by investing in both Natera and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Natera and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Natera Inc and Fate Therapeutics, you can compare the effects of market volatilities on Natera and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Natera with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Natera and Fate Therapeutics.
Diversification Opportunities for Natera and Fate Therapeutics
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Natera and Fate is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding Natera Inc and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Natera is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Natera Inc are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Natera i.e., Natera and Fate Therapeutics go up and down completely randomly.
Pair Corralation between Natera and Fate Therapeutics
Given the investment horizon of 90 days Natera Inc is expected to generate 0.52 times more return on investment than Fate Therapeutics. However, Natera Inc is 1.91 times less risky than Fate Therapeutics. It trades about 0.13 of its potential returns per unit of risk. Fate Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 12,499 in Natera Inc on September 25, 2024 and sell it today you would earn a total of 3,689 from holding Natera Inc or generate 29.51% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Natera Inc vs. Fate Therapeutics
Performance |
Timeline |
Natera Inc |
Fate Therapeutics |
Natera and Fate Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Natera and Fate Therapeutics
The main advantage of trading using opposite Natera and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Natera position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.Natera vs. Fate Therapeutics | Natera vs. Caribou Biosciences | Natera vs. Karyopharm Therapeutics | Natera vs. X4 Pharmaceuticals |
Fate Therapeutics vs. Atara Biotherapeutics | Fate Therapeutics vs. Sana Biotechnology | Fate Therapeutics vs. Caribou Biosciences | Fate Therapeutics vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance |